|
|---|
Category:License-Fitness for Duty (FFD) Performance Report
MONTHYEARML24058A1582024-02-27027 February 2024
Constellation Energy Generation, LLC Submittal of Fitness for Duty Performance Data Reports for 2023 Per 10 CFR 26.717(c) & 10 CFR 26.203
ML24030A7362024-01-30030 January 2024
Single Positive Test Form Collected on 12/07/2023
ML24030A7342024-01-30030 January 2024
Single Positive Test Form Collected on 10/16/2023
ML24030A7332024-01-30030 January 2024
Single Positive Test Form Collected on 10/16/2023
ML24030A7322024-01-30030 January 2024
Single Positive Test Form Collected on 06/12/2023
ML24030A7312024-01-30030 January 2024
Single Positive Test Form Collected on 06/12/2023
ML23044A3082023-02-13013 February 2023
Single Positive Test Form Collected on 09/20/2022
ML23044A3072023-02-13013 February 2023
Single Positive Test Form Collected on 04/19/2022
ML23044A3092023-02-13013 February 2023
Single Positive Test Form Collected on 11/28/2022
ML23044A3242023-02-13013 February 2023
Annual Report Form for Drug and Alcohol Tests for 2022
ML22140A2492022-05-20020 May 2022
Single Positive Test Form Collected on 01/06/2020
ML22140A2502022-05-20020 May 2022
Annual Report Form for Drug and Alcohol Tests for 2020
ML22042B3022022-02-11011 February 2022
Annual Report Form for Drug and Alcohol Tests for 2021
ML22033A2482022-02-0202 February 2022
Single Positive Test Form Collected on 11/08/2021
ML22033A2552022-02-0202 February 2022
Single Positive Test Form Collected on 11/17/2021
ML22033A2492022-02-0202 February 2022
Single Positive Test Form Collected on 11/16/2021
ML22033A2542022-02-0202 February 2022
Single Positive Test Form Collected on 11/30/2021
ML22033A2502022-02-0202 February 2022
Single Positive Test Form Collected on 11/30/2021
ML22033A2532022-02-0202 February 2022
Single Positive Test Form Collected on 11/30/2021
ML22033A2512022-02-0202 February 2022
Single Positive Test Form Collected on 11/30/2021
ML22033A2522022-02-0202 February 2022
Single Positive Test Form Collected on 11/01/2021
RS-20-017, Fitness for Duty Performance Data Report-Annual 20192020-02-27027 February 2020
Fitness for Duty Performance Data Report-Annual 2019
ML20057D1402020-02-26026 February 2020
Annual Fatigue Report Form for 2019
ML20030A0452020-01-30030 January 2020
Annual Report Form for Drug and Alcohol Tests for 2019
ML20028D7132020-01-28028 January 2020
Single Positive Test Form Collected on 08/21/2019
ML19056A3842019-02-25025 February 2019
Annual Fatigue Report Form for 2018
RS-19-034, Fitness for Duty Performance Data Report-Annual 2018 (Cover Letter)2019-02-25025 February 2019
Fitness for Duty Performance Data Report-Annual 2018 (Cover Letter)
ML19038A2972019-02-0707 February 2019
Single Positive Test Form Collected on 07/31/2018
ML19030B0502019-01-30030 January 2019
Annual Report Form for Drug and Alcohol Tests for 2018
ML19003A4172019-01-0303 January 2019
Single Positive Test Form Collected on 07/31/2018
ML19003A4182019-01-0303 January 2019
Single Positive Test Form Collected on 08/28/2018
ML18270A4532018-09-27027 September 2018
Annual Report Form for Drug and Alcohol Tests for 2016
ML18269A2452018-09-26026 September 2018
Annual Report Form for Drug and Alcohol Tests for 2016
ML18269A2492018-09-26026 September 2018
Single Positive Test Form Collected on 09/30/2016
RS-18-025, Submittal of Fitness for Duty Performance Data Reports for the Year 20172018-02-28028 February 2018
Submittal of Fitness for Duty Performance Data Reports for the Year 2017
ML18058A8162018-02-27027 February 2018
Annual Fatigue Report Form for 2017
ML18037A8662018-02-0606 February 2018
Annual Report Form for Drug and Alcohol Tests for 2017
ML18009A1102018-01-0909 January 2018
Single Positive Test Form Collected on 09/05/2017
ML18009A1202018-01-0909 January 2018
Single Positive Test Form Collected on 09/18/2017
ML18009A1192018-01-0909 January 2018
Single Positive Test Form Collected on 09/12/2017
ML18009A1182018-01-0909 January 2018
Single Positive Test Form Collected on 09/14/2017
ML18009A1172018-01-0909 January 2018
Single Positive Test Form Collected on 09/11/2017
ML18009A1162018-01-0909 January 2018
Single Positive Test Form Collected on 09/08/2017
ML18009A1152018-01-0909 January 2018
Single Positive Test Form Collected on 09/07/2017
ML18009A1142018-01-0909 January 2018
Single Positive Test Form Collected on 9/14/2017
ML18009A1132018-01-0909 January 2018
Single Positive Test Form Collected on 9/11/2017
ML18009A1122018-01-0909 January 2018
Single Positive Test Form Collected on 8/29/2017
ML18009A1112018-01-0909 January 2018
Single Positive Test Form Collected on 08/14/2017
ML18009A1092018-01-0909 January 2018
Single Positive Test Form Collected on 02/13/2017
ML17058A3552017-02-27027 February 2017
Annual Fatigue Report Form for 2016
2024-02-27
[Table view] |
Text
FFD Program Performance Data Reporting System Annual Reporting Form for Drug and Alcohol Tests Period of Report 2013 Total size of the random testing pool throughout the period (Calculated) 1,016 Average number of
contractors/vendors 310 Average number of
licensee employees 706 6 819 1 68 53 0 1 1 0 135 361 0 2 3 Note: 1) All fields required except those marked 'optional'.
- 2) Use Adobe Reader 8 or later for this form to work properly.
- 3) Hold your mouse over a form field to view additional information.
Annual random testing percentage achieved for the testing pool 48.8 Substances Tested Did your program only test for NRC-required substances
AND at the NRC-specified minimum cutoff levels? (Yes / No)
Yes Substance Use Only NRC Cutoff Levels? (Yes / No)
Initial Cutoff Confirmatory Cutoff LOD Testing? (Yes / No)
Comment (Optional)
Alcohol Yes Not Applicable Cocaine Yes Yes Marijuana Yes Yes Amphetamines Yes Yes Opiates Yes Yes PCP Yes Yes FFD Program Random Testing Population and Rate Select Facility T hree Mile Island [50-289]
Submission
Update 113 Reason For Testing Licensee Employees Total Number of Positive, Adulterated, Substituted, and Refusal to Test Results Contractors/Vendors Random Pre-Access For Cause Followup Post-Event Does your program conduct LOD testing
permitted in 26.163(a)(2)? (Yes / No)
Yes Yes Identify your HHS-Certified Laboratory(ies)
Medtox 26.717(d) Reporting Positive Initial Drug Test Results (Marijuana and Cocaine) - Licensee Testing Facility (LTF)
Substance Cocaine Marijuana Total (Calculated)
LTF Results MRO Determinations HHS Laboratory Results Enter values into this table if your program terminates an individual's authorization or takes administrative action on the ini tial positive test result.
Identify your Blind Performance Test Sample supplier(s)
ElSohly Laboratory Testing Total Number of Tests Conducted Tests Conducted in the Calendar Year 7 1,025 531 Total (Calculated)- Page 1 of 2 -
No Does your program use a Licensee Testing Facility?
(Yes / No)
Does your program terminate an individual's authorization or take administrative action on initial marijuana or cocaine positive test results
from your licensee testing facility (26.717(d))? (Yes / No)
Annual Report Form (version 1.5.1 - February 12, 2014)(EIE General Submission Portal)
Total Number of "Dilute" Specimens (Special Analyses Testing Conducted) 0 Total Number of "Dilute" Specimen Test Results (Optional)
Special Analyses Testing Results Save to Local PC Print this Report Final Step (Required) -
NRC will consider this form authentic in accordance with 26.11 only when the "Validate & Lock" button has been selected and all errors (i.e., those highlighted in red) have been corrected. The "Validate & Lock" button will change to "Locked" after the data valid ation process has been successfully completed and the form is ready for submission.
Locked Form Locked On:
A pr 29, 2014 at 6:23:28 PM Topic 1 Description (1) Licensee reported 29 C/V tests under the category "Pre-Access Random." These tests were included under the Pre-Access category.
Summary of Management Actions - 26.717(b)(8)
Topic 1 Other(s)Please elaborate:
Form does not provide a separate field to capture this data.
Topic 2 Description There were two (2) re-analysis performed for this reporting period and both were re-confirmed.
Topic 2 Program and System Management Add an additional Topic Summarize actions implemented to improve FFD program performance. As applicable, reference in the topic description audit repo rts, 30-day reports, and/or corrective action reports. If reporting information on more than three topics, select "Others" for Topic 3 to report any addit ional topics.
Person(s) Responsible for Information Provided Company Email Address susan.techau@exeloncorp.com First Name Susan Position Title A A/FFD Program Manager Position Title First Name Last Name Last Name Techau Company Email Address Person 1 (required):
Person 2 (optional):
Annual Report Form (version 1.5.1 - February 12, 2014)- Page 2 of 2 -
Substances Tested -
continued Three Mile Island [50-289]Period of Report:2013
